128 related articles for article (PubMed ID: 2389624)
1. Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
Resch H; Pietschmann P; Krexner E; Woloszczuk W; Willvonseder R
Acta Endocrinol (Copenh); 1990 Jul; 123(1):14-8. PubMed ID: 2389624
[TBL] [Abstract][Full Text] [Related]
2. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
Resch H; Pietschmann P; Willvonseder R
Calcif Tissue Int; 1989 Oct; 45(4):209-13. PubMed ID: 2509007
[TBL] [Abstract][Full Text] [Related]
3. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
Christiansen C; Riis BJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
[TBL] [Abstract][Full Text] [Related]
4. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
Riis BJ; Johansen J; Christiansen C
Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
[TBL] [Abstract][Full Text] [Related]
5. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
8. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
Bone; 1989; 10(5):313-20. PubMed ID: 2690898
[TBL] [Abstract][Full Text] [Related]
9. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
10. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Marslew U; Overgaard K; Riis BJ; Christiansen C
Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
[TBL] [Abstract][Full Text] [Related]
11. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
[TBL] [Abstract][Full Text] [Related]
12. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Gennari C; AgnusDei D; Gonnelli S; Nardi P
Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
[TBL] [Abstract][Full Text] [Related]
13. Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.
Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
Clin Endocrinol (Oxf); 1993 Dec; 39(6):649-55. PubMed ID: 8287582
[TBL] [Abstract][Full Text] [Related]
14. Prevention of bone mineral loss in postmenopausal women by norethisterone.
Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
[TBL] [Abstract][Full Text] [Related]
17. Short term effects of SHD 386L and levonorgestrel on bone and mineral metabolism in the postmenopause: a double-blind randomised placebo-controlled trial.
Purdie DW; Hay AW; Everett M
Maturitas; 1992 Mar; 14(3):189-99. PubMed ID: 1508060
[TBL] [Abstract][Full Text] [Related]
18. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
[TBL] [Abstract][Full Text] [Related]
19. [The effect of hormone replacement therapy on bone mineral content and on fractures].
Eiken PA
Ugeskr Laeger; 1997 Jan; 159(5):570-6. PubMed ID: 9045445
[TBL] [Abstract][Full Text] [Related]
20. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
